Imaging assessment of osteosarcoma in childhood and adolescence: Diagnosis, staging, and evaluating response to chemotherapy

Cancer Treatment and Research

Volumn 152, Issue , 2009, Pages 33-62

  Eftekhari, Farzin ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; TECHNETIUM 99M;

ADOLESCENT; ANGIOGRAPHY; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER LOCALIZATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DRUG MONITORING; ECHOGRAPHY; HUMAN; IMAGE ANALYSIS; LUNG METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; SECOND CANCER; TREATMENT RESPONSE; TUMOR NECROSIS; WHOLE BODY IMAGING; BONE; BONE NEOPLASMS; DIAGNOSTIC USE; PATHOLOGY; SCINTISCANNING;

ADOLESCENT; BONE AND BONES; BONE NEOPLASMS; CHILD; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM STAGING; OSTEOSARCOMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77953677656     PISSN: 09273042     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-0284-9_3     Document Type: Conference Paper

References (27)

1. Mira JM. Osseous tumors of intramedullary origin. In: Mira JM, ed. Bone Tumors: Clinical, Radiologic, and Pathologic Correlations. Philadelphia, Pa: Lea & Febriger; 1989:248-438.
2. Resnick D, Kyriakos M, Greenway GD. Tumor-like diseases of bone: imaging and pathology of specific lesions. In: Resnick D, ed. Diagnosis of Bone and Joint Disorders. 3rd ed. Philadelphia: Saunders; 1995:3662-3697.
3. Huvos AG. Osteogenic sarcoma. Bone Tumors: Diagnosis, Treatment, and Prognosis. Philadelphia, Pa: Saunders; 1991:85-156.
4. Dahlin DC, Coventy MB. Osteogenic sarcoma. A study of six hundred cases. J Bone Joint Surg [Am]. 1967;49:101-110.
5. Jaffe N, Spears R, Eftekhari F, et al. Pathologic Fracture in Osteosarcoma: Impact of chemotherapy on primary tumor and survival. Cancer. 1987;59:701-709.
6. Hopper KD, Moser RP, Haseman DB, et al. Osteosarcomatosis. Radiology. 1990;175:233-239.
7. Weatherby RP, Dahlin DC, Ivins JC. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc. 1981;56:294-306.
8. Lorigan JG, Libshitz HI, Peuchot M. Radiation-induced sarcoma of the bone: CT findings in 19 cases. AJR. 1989;153:791-794.
9. Kawai A, Sugihara S, Kunisada T, et al. Imaging assessment of the response of bone tumors to preoperative chemotherapy. Clin Orthop Relat Res. 1997;337:216-225.
10. Kunisada T, Ozaki T, Kawai A. Imaging assessment of the responses of osteosarcoma patients to preoperative chemotherapy: angiography compared with thallium-201 scintigraphy. Cancer. 1999;86(6):949-956.
11. Carrasco CH, Charnsangavej C, Raymond AK, et al. Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology. 1989;170:839-842.
12. Lang P, Vahlensieck M, Matthay KK. Monitoring neovascularity as an indicator to response to chemotherapy in osteogenic and Ewing sarcoma using magnetic resonance angiography. Med Pediatr Oncol. 1996;26(5):329-333.
13. Chung VP, Benjamin R, Jaffe N, et al. Radiographic and angiographic changes in oseosarcoma after intraarterial chemotherapy. AJR. 1982;139:1065-1069.
14. Kumpan W, Lechner G, Wittich GR. The angiographic response of osteosarcoma following pre-operative chemotherapy. Skeletal Radiol. 1986;15(2):96-102.
15. Wilkins RM, Cullen JW, Odom L. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol. 2003;10(5):481-483.
16. Van der Woude HJ, Bloem JL, van Oostayen JA, et al. Treatment of high-grade bone sarcomas with neoadjuvant chemotherapy. The utility of sequential color Doppler sonography in predicting histopathologic response. AJR. 1995;165:125-133.
17. Abudu A, Davies AM, Pysent PB, et al. Tumour volume as a predictor of necrosis after chemotherapy in Ewing's sarcoma. J Bone Joint Surg Br. 1999;81:317-322.
18. Holscher HC, Bloem JL, Vanel D, et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology. 1992;182:839-844.
19. Pan G, Raymond AK, Carrasco CH, et al. Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology. 1990;174:517-526.
20. Marcal L, Choi H, Jackson E, et al. Use of Quantitative Dynamic Contrast MR Imaging to Monitor Musculoskeletal Sarcomas: Correlation with FDG PET and Pathology. E-poster. International Society for Magnetic Resonance in Medicine (ISMRM), Kyoto, Japan. 2004, May 15-21.
21. De Baere T, Vanel D, Shapeero LG, et al. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology. 1992;185:587-592.
22. Shapeero LG, Vanel D. Imaging evaluation of the response of high-grade osteosarcoma and Ewing sarcoma to chemotherapy with emphasis on dynamic contrast-enhanced magnetic resonance imaging. Semin Musculoskelet Radiol. 2000;4:137-146.
23. Vanel D, Verstraete KL, Shapeero LG. Primary tumors of the musculoskeletal system. Radiol Clin North Am. 1997;35:213-237.
24. Wunder JS, Paulian G, Huvos AG, et al. The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma. J Bone Joint Surg Am. 1998;80:1020-1033.
25. Shankar LK, Hoffman JM, Bacharach S, et al. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute trials. J Nucl Med. 2006;47:1059-1066.
26. Brenner W, Bohuslavizki KH, Eary JF. PET imaging of osteosarcoma. J Nucl Med. 2003;44:930-942.
27. Eary JF, Conrad EU, Bruckner JD, et al. Quantitative [F-18] fluorodeoxyglucose positron emission tomography in pretreatment grading of sarcoma. Clin Cancer Res. 1998;4:1215-1220.